Statistics
Description
FMS is a chronic, widespread musculoskeletal pain and fatigue disorder for which the cause is unknown, but significant
abnormalities in the central nervous system have been uncovered in recent years.
The majority of Fibro patients become ill after a physical trauma (such as an auto accident or head injury), there also appears to be a genetic link
as well as a possible link to certain viruses.
In addition to the pain and fatigue, other symptoms include chronic headaches/migraines (50% suffer with migraines),
morning stiffness, cognitive or memory impairments, reduced coordination and decreased endurance,
unrefreshed sleep (likely due to a number of sleep anomalies), exercise intolerance, blurred vision.... The
American College of Rheumatology published the diagnostic criteria for FMS in 1990. This selection criteria was shown
to be 88% accurate in its ability to identify patients with this syndrome. Researchers have noted a significant overlap
between FMS and CFS (Chronic Fatigue Syndrome). A majority of these patients meet both diagnostic criteria for FMS and the CDC criteria for CFS.
Other Conditions Which Are Extremely Common with Fibromyalgia
Include:
Demographics
Research studies indicate that 2% of the general population are afflicted with FMS. This amounts to roughly five million
Americans. The majority of FMS patients are female, and symptoms may begin in young, school-aged children.
The average person takes five years and spends thousands of dollars in medical bills to receive this diagnosis--all
because few physicians possess the education or tools to diagnose and treat FMS. One study revealed that prior
to diagnosis, 60% of the patients with FMS underwent costly, unsuccessful surgeries in an attempt to "cut out" their
excruciating pain. Only 6% of them had the correct diagnosis before entering the study. Even with a diagnosis, there
is no single therapeutic agent capable of controlling the symptoms of FMS.
Disability Studies
Four (4) reports have shown that FMS can be as disabling as rheumatoid arthritis or RA. RA is listed in the Social
Security Disability law book, but FMS is not. Due to the difficulties in gaining recognition for FMS as a disabling illness,
the percentage of patients drawing SSD payments based on FMS is only 16.2%. Yet, nearly 30% of FMS patients
claim that they cannot hold down a steady job due to this condition. The health care costs per patient per year have been
documented at $2,274 despite the poor treatment outcomes. The total yearly drain on the U.S. economy is estimated
to be over $20 billion.
100 out of 394 patients (that is 25.3%) with FMS (all female)
and 12 out of 44 males (27%) were shown in a recent survey to be
sufficiently badly affected by the condition as to be unable to
work - they were effectively disabled.
Almost all the others surveyed claimed that their FMS affected
their job performance very badly.
Current Status of FMS-related Research Spending by NIH
Most FMS research at NIH is sponsored by NIAMS (National Institute of Arthritis, Musculoskeletal and Skin diseases). At the end of 1993, NIAMS announced a $1.4 million RFA for FMS but, unfortunately, they awarded less than $1 million of the RFA in 1994. The 1997 FMS research funding level at NIAMS measured out to only 0.6% of their annual budget of $257 million ... not much for the second most common rheumatic disease that they supposedly represent. Many highly significant research findings in FMS are related to abnormalities in central nervous system function, yet the Neurological Institute (NINDS) has not spent one penny on FMS research.
*** Much of the information and statistics come from: